This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of levodopa decarboxylase inhibitor
PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
4330 |
4. Check minimum number of events
Min. number of events
3
|
4330 |
5. Include endpointsNone |
4330 |
6. Filter based on genotype QC (FinnGen only) |
4196 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF2
Use of levodopa decarboxylase inhibitor
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4196 | 1690 | 2506 |
| Unadjusted period prevalence (%) | 1.02 | 0.66 | 1.26 |
| Median age at first event (years) | 71.01 | 69.99 | 71.70 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR – Use of levodopa decarboxylase inhibitor
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).